Raymond James’s $280 target on JNJ

JNJ Johnson & Johnson

$254 → $280 (+10%) by Aug 2027

Outperform · raises · said Aug 3, 2026 · 12-month default horizon

Open: judged on the close on Aug 3, 2027

The article this target came from

Raymond James raises Johnson & Johnson price target on robotic surgery

Investing.com · Aug 3, 2026

Raymond James raised its price target on Johnson & Johnson shares to $280 from $265 while maintaining an Outperform rating.

Raymond James’s track record → Johnson & Johnson →

A fact about what Raymond James published, as reported by Investing.com, not a recommendation from Dalsna Finance; Raymond James is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.